Stock ABSI ABSCI CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Absci Corporation

Equities

ABSI

US00091E1091

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
4.52 USD +3.20% Intraday chart for Absci Corporation +6.35% +7.62%
Jun. 10 Absci Seeks M&A Opportunity CI
Jun. 10 Transcript : Absci Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 02:00 PM

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GL
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
GL
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
GL
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
AQ
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GL
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
GL
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
GL
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
AQ
Absci Announces Pricing of Public Offering of Common Stock
GL
Absci Announces Proposed Public Offering of Common Stock
GL
Absci Announces Proposed Public Offering of Common Stock
AQ
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
GL
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
AQ
Absci to Participate in Upcoming Investor Conferences
GL
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
GL
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
AQ
Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
GL
Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
AQ
Absci to Participate in the 26th Annual Needham Growth Conference
GL
Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABSI Stock
  4. News Absci Corporation
  5. Press Releases